Gsk (GSK) Times Interest Earned (2009 - 2026)
Gsk (GSK) posted quarterly Times Interest Earned of -$2.14 for Q2 2026, up 77.07% year-over-year from -$1.21 in Q2 2025, and up 92.08% quarter-over-quarter from -$26.98 in Q1 2026.
Gsk (GSK) Times Interest Earned (2009 - 2026) Analysis & Trends
Gsk's Times Interest Earned history runs 18 years deep, the most recent figure standing at -$2.14 for Q2 2026.
- In Q2 2026, Times Interest Earned rose 77.07% year-over-year to -$2.14; the TTM figure through Jun 2026 stood at -$11.09 (down 16.75% YoY), while the FY2025 annual figure was $11.32, up 88.26% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$2.14, up from -$26.98 in the prior quarter.
- The five-year high for Times Interest Earned was -$2.14 in Q2 2026, with the low at -$177.18 in Q3 2023.
- The 5-year median for Times Interest Earned is -$10.31 (2023), against an average of -$25.58.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned tumbled 554.58% in 2023, then jumped 91.79% in 2024.
- Gsk's Times Interest Earned stood at -$4.3 in 2022, then plunged by 119.04% to -$9.43 in 2023, then soared by 32.65% to -$6.35 in 2024, then retreated by 27.19% to -$8.07 in 2025, then soared by 73.52% to -$2.14 in 2026.
- Business Quant data shows GSK's Times Interest Earned at -$2.14 in Q2 2026, -$26.98 in Q1 2026, and -$8.07 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.14 |
| Mar 31, 2026 | -26.98 |
| Dec 31, 2025 | -8.07 |
| Sep 30, 2025 | -76.26 |
| Jun 30, 2025 | -9.32 |
| Mar 31, 2025 | -32.12 |
| Dec 31, 2024 | -6.35 |
| Sep 30, 2024 | -14.54 |
| Jun 30, 2024 | -6.66 |
| Mar 31, 2024 | -20.99 |
| Dec 31, 2023 | -9.43 |
| Sep 30, 2023 | -177.18 |
| Jun 30, 2023 | -7.26 |
| Mar 31, 2023 | -17.35 |
| Dec 31, 2022 | -4.30 |
| Sep 30, 2022 | -27.07 |
| Jun 30, 2022 | -3.21 |
| Mar 31, 2022 | -11.19 |
| Dec 31, 2021 | -3.28 |
| Sep 30, 2021 | -7.08 |